Skip to main content

Peer Review reports

From: Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study

Original Submission
8 Nov 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
6 May 2022 Reviewed Reviewer Report - Pier Leopoldo Capecchi
17 Sep 2022 Reviewed Reviewer Report
24 Sep 2022 Reviewed Reviewer Report
10 Oct 2022 Reviewed Reviewer Report - Emmanouil P. Pappou
4 Nov 2022 Author responded Author comments - Michio Nakamura
Resubmission - Version 5
4 Nov 2022 Submitted Manuscript version 5
8 Nov 2022 Author responded Author comments - Michio Nakamura
Resubmission - Version 6
8 Nov 2022 Submitted Manuscript version 6
21 Nov 2022 Reviewed Reviewer Report
22 Nov 2022 Reviewed Reviewer Report - Pier Leopoldo Capecchi
22 Nov 2022 Reviewed Reviewer Report - Emmanouil P. Pappou
3 Dec 2022 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
5 Dec 2022 Editorially accepted
16 Dec 2022 Article published 10.1186/s12885-022-10403-y

You can find further information about peer review here.

Back to article page